InvestorsHub Logo
Followers 60
Posts 14524
Boards Moderated 1
Alias Born 01/04/2003

Re: None

Thursday, 06/10/2004 1:12:23 PM

Thursday, June 10, 2004 1:12:23 PM

Post# of 83044
The Stock Structure of IBCS from the beginning to present....

http://www.nasdaq.com/asp/quotes_sec.asp?symbol=IBCS&selected=IBCS&page=filings

9/01 - 70,849,900

12/01 - 76,149,900
Why: 4. STOCKHOLDERS' EQUITY

The Board of directors is authorized, to issue up to an aggregate of 10,000,000 shares of preferred stock in one or more series. The directors may fix rights, preferences and privileges of the shares of each series. No shares have been issued as of December 31, 2001.

The founders of the Company were issued 50,000,000 shares of common stock at par value for a total of $5,000.

In April 2001, the Company had a private placement offering whereby 5,000,000 shares of common stock were sold for $25,000.


F-9
The Company sold 105.666 units in a private placement for a total of $158,325 (net proceeds of $103,392). Each unit consists of 150 shares of common stock, 20 Series A warrants, 50 Series B warrants and 30 Series C warrants. The Series A warrant included in each Unit entitles the holder to purchase 20 shares of common stock of the Company at a purchase price of $.25 per share. The Series B warrant included in each unit entitles the holder to purchase 50 shares of common stock of the Company at a purchase price of $.37 per share. The Series C warrant included in each unit entitles the holder to purchase 30 shares of common stock of the Company at a purchase price of $.50 per share. The warrants shall expire on April 25, 2006. The Company may call any warrant series or all of the warrants at a call price of $.001 per underlying share should the Company's common stock trade at or above $1.00 per share, based on the reported closing bid price of the common stock, for ten consecutive trading days following 15 days prior written notice of the Company's intention to call the warrants. In the event the warrants or warrant series subject to call have not been exercised by written notice within such 15-day notice period, the warrants will cease to exist.
5. STOCK OPTION PLAN

On August 8, 2001, the board of directors and the holders of a majority of the outstanding shares of common stock adopted the 2001 stock option plan. 5,000,000 shares of common stock are reserved for issuance upon exercise of options granted from time to time under the 2001 stock option plan.

Under the stock option plan the Company may grant incentive stock options to key employees and employee directors, or grant non-qualified options to employees, officers, directors and consultants. The 2001 stock option plan is currently administered by the board of directors.

Subject to the provisions of the stock option plan, the board will determine who shall receive options, the number of shares of common stock that may be purchased under the options, the time and manner of exercise of options and exercise prices. The term of options granted under the stock option plan may not exceed ten years or five years for an incentive stock option granted to an optionee owning more than 10% of the Company's voting stock. The exercise price for incentive stock options will be equal to or greater than 100% of the fair market value of the shares of the common stock at the time granted. However, the incentive stock options granted to a 10% holder of the Company's voting stock are exercisable at a price equal to or greater than 110% of the fair market value of the common stock on the date of the grant. The exercise price for non-qualified options will be set by the board in its discretion. The exercise price may be payable in cash or, with the approval of the board, by delivery of shares or by a combination of cash and shares. Shares of common stock received upon exercise of options will be subject to restrictions on sale or transfer. As of December 31, 2001 no options have been granted under the 2001 stock option plan.

3/02 - 76,149,900

6/02 - 76,149,900

9/02 - 76,149,900

12/02 - 76,149,900

3/03 - 76,149,900

6/03 - 76,149,900

9/03 - 89,149,900

Why: 6. STOCKHOLDERS' EQUITY

The Board of directors is authorized, to issue up to an aggregate of 10,000,000 shares of preferred stock in one or more series. The directors may fix rights, preferences and privileges of the shares of each series. No shares have been issued as of December 31, 2003.

In January of 2002 we raised an additional $53,000 from the sale of 5,300,000 shares of common stock.

The founders of the Company were issued 50,000,000 shares of common stock at par value for a total of $5,000.

The Company sold 105.666 units in a private placement for a total of $158,325 (net proceeds of $103,392). Each unit consists of 150,000 shares of common stock, 20 Series A warrants, 50 Series B warrants and 30 Series C warrants. The Series A warrant included in each Unit entitles the holder to purchase 20 shares of common stock of the Company at a purchase price of $.25 per share. The Series B warrant included in each unit entitles the holder to purchase 50 shares of common stock of the Company at a purchase price of $.37 per share. The Series C warrant included in each unit entitles the holder to purchase 30 shares of common stock of the Company at a purchase price of $.50 per share. The warrants shall expire on April 25, 2006. The Company may call any warrant series or all of the warrants at a call price of $.001 per underlying share should the Company's common stock trade at or above $1.00 per share, based on the reported closing bid price of the common stock, for ten consecutive trading days following 15 days prior written notice of the Company's intention to call the warrants. In the event the warrants or warrant series subject to call have not been exercised by written notice within such 15-day notice period, the warrants will cease to exist.

During the year ended December 31, 2003 the Company issued 9,570,000 shares of common stock pursuant to form S-8 to four consultants for services rendered. The value of these shares is $275,210 or approximately $.03 per share which was the fair market value on the date of issuance. The Company issued an additional 300,000 retricted shares of common stock to two consultants valued at $6,300 or approximately $.02 per share which was the fair market value on the date of issuance.

12/03 - 89,219,900

3/04 - 89,219,900

I DON'T see ANY untoward delution......Do You???


We'll Get there. Just you wait and see....
(Posting news is what I do. It DOESN'T mean I own it!!:-)

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.